Medication info
Sitaglutin Tablet 100 Milligrams (Sitagliptin Hydrochloride Hydrate)

Sitaglutin Tablet 100 Milligrams (Sitagliptin Hydrochloride Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Sitagliptin Hydrochloride Hydrate›113.4mg / 1 tablet
Manufacturer / importer
Ilhwa Co., Ltd.
Appearance
Orange, round, biconvex film-coated tablet
Packaging
30 tablets/box [(10 tablets/PTP x 3)]
Approval status
Active

MFDS item code 202302013 · Approved 2023.06.30 · Insurance code 640904580

Summary

Main use
Improves blood glucose control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
This medicine is administered at 100 mg once daily as monotherapy or in combination therapy; the maximum daily dose is 100 mg. This medicine may be taken regardless of meals. When coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions, 5. General Precautions). Patients with renal impairment Because dose adjustment according to renal function is necessary, assessment of renal function before and periodically after administration of this medicine is recommended. 1. No dose adjustment is necessary in patients with mild renal impairment (glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dose adjustment is necessary in patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. Administer 50 mg once daily in patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). 4. Administer 25 mg once daily in patients with severe renal impairment (glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medicine may be administered regardless of the timing of dialysis.

Ingredients

Manufacturer
Ilhwa Co., Ltd.

Efficacy & effects

Improves blood glucose control in type 2 diabetes mellitus

View approved original text

This medication is used to improve blood sugar control in patients with type 2 diabetes. It can be administered alone or in combination with other treatments to complement dietary guidance and exercise therapy. This helps to manage blood sugar levels reliably and improve diabetes symptoms.

How to take

Adult dose

This medicine is administered at 100 mg once daily as monotherapy or in combination therapy; the maximum daily dose is 100 mg. This medicine may be taken regardless of meals. When coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions, 5. General Precautions). Patients with renal impairment Because dose adjustment according to renal function is necessary, assessment of renal function before and periodically after administration of this medicine is recommended. 1. No dose adjustment is necessary in patients with mild renal impairment (glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dose adjustment is necessary in patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. Administer 50 mg once daily in patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). 4. Administer 25 mg once daily in patients with severe renal impairment (glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medicine may be administered regardless of the timing of dialysis.

Precautions

This medication can cause severe allergic reactions; if you notice sudden skin rashes, difficulty breathing, or swelling of the face or neck after taking this medication, stop taking it immediately and consult a doctor. While taking this medication, there is a possibility of developing a serious condition called pancreatitis, which is an inflammation of the pancreas, so if symptoms such as abdominal pain, nausea, or vomiting appear, inform healthcare personnel immediately. This medication should not be used in patients with type 1 diabetes or diabetic ketoacidosis, and patients who have had severe allergic reactions to this drug or its components should avoid it. Patients with impaired kidney function may experience delayed excretion of this medication, so they should take a lower dose than prescribed by their doctor and have regular kidney function tests. There is a risk of hypoglycemia when used alone or in combination with other diabetes medications, so if symptoms of hypoglycemia such as dizziness, cold sweat, or tremor occur, appropriate measures should be taken immediately. Symptoms such as headaches, upper respiratory infections, nasopharyngitis, diarrhea, and abdominal pain may occur during treatment. If these symptoms are severe or persistent, consulting a doctor is recommended. Safety during pregnancy has not been established, so pregnant women should avoid using this medication, and nursing women should also refrain from its use, as this medication may be secreted in breast milk. Safety and effectiveness in children and adolescents under 18 years of age have not been adequately studied, so its use in this age group is not recommended. Elderly patients are more likely to have decreased kidney function, which may require dosage adjustments; therefore, it is important to undergo regular kidney function tests during treatment. In case of overdose, seek medical treatment immediately, as this medication can be partially removed by hemodialysis, and dialysis treatment may be considered in severe overdose cases. If symptoms such as joint pain or skin blistering appear while taking this medication, inform a doctor immediately and stop taking it.

Side effects

  • Severe allergic reactions
  • anaphylaxis
  • angioedema
  • Stevens-Johnson syndrome
  • exfoliative dermatitis
  • acute pancreatitis
  • hypoglycemia
  • upper respiratory infection
  • nasopharyngitis
  • headache
Show 30 more
  • diarrhea
  • abdominal pain
  • nausea
  • peripheral edema
  • dyspepsia
  • dizziness
  • elevated liver enzyme levels
  • acute renal failure
  • constipation
  • vomiting
  • severe and disabling arthralgia
  • bullous pemphigoid
  • myalgia
  • limb pain
  • back pain
  • interstitial lung disease
  • pruritus
  • thrombocytopenia
  • rhabdomyolysis
  • pneumonia
  • diabetes complications
  • metabolic acidosis
  • falls
  • cardiac arrest
  • elevated serum triglycerides
  • gastritis
  • weight loss
  • hypertension
  • hypernatremia
  • erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air and moisture from entering. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius.

Appearance and packaging

Appearance

Orange, round, biconvex film-coated tablet

Package unit

30 tablets/box [(10 tablets/PTP x 3)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.